CNBC

Eli Lilly hits $1 trillion market value, a first for a health-care company

21 11 月, 2025

One Min Read

8 Views

The pharmaceutical giant Eli Lilly’s stock has been riding the skyrocketing demand for its weight loss injection Zepbound and diabetes treatment Mounjaro.

原文: https://www.cnbc.com/2025/11/21/eli-lilly-hits-1-trillion-market-value-first-for-health-care-company.html

Last Update: 21 11 月, 2025

Written By

Future Wealths

Anaergia股价上涨，在圣地亚哥获得4380万加元合同

CNBC

Retail investors are running head first into this topsy-turvy market

1 Min Read

CNBC

Third Point, D.E. Shaw obtain agreements with CoStar. How the activists can build value

1 Min Read

CNBC

Top Wall Street analysts find these 3 stocks attractive in these challenging times

1 Min Read

Main Menu

Main Menu

Eli Lilly hits $1 trillion market value, a first for a health-care company

Other Articles

Anaergia股价上涨，在圣地亚哥获得4380万加元合同

<div>Bybit Advances Regulatory Dialogue at Argentina’s Regulation Day 2025, Spotlighting Crypto’s Role in Financial Inclusion</div>

Featured Items

《品中資－羅國森》唔使問ＡＩ，都知智譜好過ＭｉｎｉＭａｘ？

时代锐评|数据优异，股价拉胯？创新药企“一炮而红”的急功近利之心不可取

香港球迷凌晨4時聚酒吧撐英格蘭　「看完返家　早上8時半上班」｜世界盃2026·短片

香港三大发钞行维持最优贷款利率不变业内预计短期难降息

Related Posts

Retail investors are running head first into this topsy-turvy market

Third Point, D.E. Shaw obtain agreements with CoStar. How the activists can build value

Top Wall Street analysts find these 3 stocks attractive in these challenging times

What are you looking for?

Main Menu

What are you looking for?

Main Menu

Eli Lilly hits $1 trillion market value, a first for a health-care company

Other Articles

Featured Items

Related Posts